This analysis examined the use of PLEX, IVIg and SCIg as maintenance therapies among participants in the Vitaccess Real MG Registry. Findings suggest that a small proportion of patients continue to require these approaches in routine management, highlighting ongoing unmet need among individuals with refractory myasthenia gravis.
Patient Preferences and Treatment Decision Drivers in IDH-Mutant Grade 2 Glioma: An International Discrete Choice Experiment
Ghiaseddin AP, Hossain-Ibrahim K, Wick A, Aubin C, Massetti M, Ragon A, Amini F, Fellows A, Aggio D (The Patient, 2026)




